Basic Information
Basic information for SNHG14-317-27aa
Peptide Name SNHG14-317-27aa
Genome Position chr15:25241562-25241642[+]
Species Human
Peptide Sequence MRLEEDFHWAHFSWASVHQPGAQPLVY
Peptide Length 27
Unique No (SNHG14-203-27aa,SNHG14-207-27aa,SNHG14-225-27aa,SNHG14-226-27aa,SNHG14-228-27aa,SNHG14-229-27aa,SNHG14-243-27aa,SNHG14-244-27aa,SNHG14-245-27aa,SNHG14-266-27aa,SNHG14-267-27aa,SNHG14-273-27aa,SNHG14-284-27aa,SNHG14-285-27aa,SNHG14-292-27aa,SNHG14-294-27aa,SNHG14-295-27aa,SNHG14-306-27aa,SNHG14-320-27aa,SNHG14-326-27aa,SNHG14-327-27aa,SNHG14-328-27aa,SNHG14-329-27aa,SNHG14-331-27aa)
Grand Average of Hydropathicity -0.4074
Relative Molecular Mass 3707.98
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000668570;SNHG14-317
Transcript Length 4660
Coding Ability 0.4803
DNA Sequence Corresponding to Peptide ATGAGACTGGAGGAAGACTTCCATTGGGCCCACTTTTCCTGGGCCAGTGTCCATCAGCCAGGTGCTCAGCCCCTGGTGTAC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :